VYNE Therapeutics Inc.: VYNE Therapeutics Initiates Phase 1b Trial of VYN202, a Novel BD2-Selective Oral BET Inhibitor, in Plaque Psoriasis
Oral, once-daily doses of VYN202 being evaluated in subjects with moderate-to-severe plaque psoriasis Top-line data from the 12-week double-blind trial expected by year-end 2025 Phase 1b trial designe ...
Valley artist celebrates Black culture through unique portraits
Kelvonnah Stidhum is the mastermind behind Fly Girl Prints, a collection of artwork that celebrates both Black culture and ...
Celebrating Black History Month with The African American Museum in Philadelphia
Today on Instagram, the palace shared portraits done by none other than Kate Middleton, Prince George, Princess Charlotte It ...
Philadelphia to honor Sadie T.M. Alexander
Sadie Tanner Mossell Alexander, the first Black woman to graduate from the University of Pennsylvania Law School and the ...